Assessing Exercise Behavior and Preferences Among Patients and Oncologists

Sponsor
Indiana University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04047589
Collaborator
(none)
350
1
63.6
5.5

Study Details

Study Description

Brief Summary

The purpose of this study is to understand the preferences and barriers surrounding exercise of both the patients and oncologists within Indiana University Simon Cancer Center. This information will establish gaps in our current care and provide important information to guide future pilot interventions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Survey regarding exercise habits, barriers to exercise, and experience with exercise services from the cancer center.
  • Behavioral: Survey regarding personal exercise habits and beliefs, barriers to making exercise recommendations

Detailed Description

This descriptive, cross-sectional study will survey patients with a current or previous diagnosis of non-metastatic solid tumor malignancy who are being seen at the Indiana University Simon Cancer in Indianapolis, Indiana. Patients with active, incurable disease are excluded. Willing and eligible patients will complete a brief, 14 question survey while seen in the waiting room of the women's or multi-disciplinary clinics. We aim to survey 350 patients over a 12 month period. Patients will fill out the survey at only one point in time and no patient identifiers will be kept.

During COVID-19 restrictions, we will also send out an electronic version of the survey to participants using the email address provided in their Cerner accounts. Responses will be captured by REDCAP and will remain anonymous and not linked to the patients' medical record or personal health information.

The physician survey will be emailed to oncologist/hematologists practicing within IUSCC who see patients at least once per week. Physicians will receive a survey at only one point in time. The survey will be anonymous and no physician identifiers will be kept.

Primary objective Estimate the proportion of patients with curable solid tumor malignancies seen at the Indiana University Simon Cancer Center who are meeting exercise recommendations for cancer survivors (more than 150 minutes per week of moderate or 75 minutes per week of vigorous activity).

Secondary objectives

  • Assess patients' perceived barriers to exercise during cancer survivorship

  • Assess patients' preferences for receiving exercise recommendations

  • Assess oncologists' perceived barriers to making exercise recommendations

  • Assess oncologists' preferences for exercise and physical activity resources that could be provided by the cancer center

Study Design

Study Type:
Observational
Anticipated Enrollment :
350 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Assessing Exercise Behavior and Preferences Among Patients and Oncologists at Indiana University Simon Cancer Center
Actual Study Start Date :
Sep 13, 2019
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Subjects

Cancer patients with curable or previously treated malignancies

Behavioral: Survey regarding exercise habits, barriers to exercise, and experience with exercise services from the cancer center.
Survey created at Indiana University to gain information regarding exercise habits, barriers to exercise, and experience with exercise services from the cancer center.

Providers

Physicians seeing patients in the outpatient clinics at the IU Simon Cancer Center

Behavioral: Survey regarding personal exercise habits and beliefs, barriers to making exercise recommendations
Survey regarding personal exercise habits and beliefs, barriers to making exercise recommendations, and potential resources the cancer center might provide to help make effective exercise recommendations in the future

Outcome Measures

Primary Outcome Measures

  1. Proportion of patients who meet exercise recommendations. [baseline]

    Patients self-reporting more than 150 minutes per week of moderate physical activity OR more than 75 minutes per week of vigorous physical activity

Secondary Outcome Measures

  1. Patient Perceived barriers to exercise during cancer survivorship via pilot survey [Baseline]

    Investigator created survey with 14 items regarding demographics, cancer history, exercise habits, and exercise as part of cancer treatment

  2. Patient preferences for receiving exercise recommendations via pilot survey [Baseline]

    Investigator created survey with 14 items regarding demographics, cancer history, exercise habits, and exercise as part of cancer treatment

  3. Provider perceived barriers to making exercise recommendations via pilot survey [Baseline]

    Investigator created survey with 14 items regarding demographics, cancer speciality, exercise habits, and exercise recommendations to patients and patient exercise habits

  4. Provider preferences for exercise and physical activity resources that could be provided by the cancer center via pilot survey [Baseline]

    Investigator created survey with 14 items regarding demographics, cancer speciality, exercise habits, and exercise recommendations to patients and patient exercise habits

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Physician survey Any oncologist/hematologist practicing within IUSCC regularly providing care for patients with solid tumor malignancies (seeing patients one or more days per week in the multidisciplinary or women's clinics with solid tumor malignancies). Physicians providing care only for hematologic (multiple myeloma, leukemia, lymphoma, transplant) or benign disorders will be excluded.

  • Patient survey

  1. Patients with a current or previous diagnosis of stage 0-III or curable solid tumor

  2. Patients receiving any component of their medical oncologic care at IUSCC

  3. Age ≥ 18 years

  4. Able to read and write English

Exclusion Criteria:
  1. Metastatic disease at the time of study participation

  2. Inability to complete the survey

Contacts and Locations

Locations

Site City State Country Postal Code
1 Indiana University Melvin & Bren Simon Cancer Center Indianapolis Indiana United States 46202

Sponsors and Collaborators

  • Indiana University

Investigators

  • Principal Investigator: Tarah Ballinger, MD, Indiana University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tarah J Ballinger, MD, Assistant Professor of Clinical Medicine, Indiana University
ClinicalTrials.gov Identifier:
NCT04047589
Other Study ID Numbers:
  • IUSCC-0690
First Posted:
Aug 7, 2019
Last Update Posted:
Jul 21, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tarah J Ballinger, MD, Assistant Professor of Clinical Medicine, Indiana University

Study Results

No Results Posted as of Jul 21, 2022